HTGF et al. in €2.6m Transcatheter Tech series-B round
High-Tech Gründerfonds (HTGF), Tubaflex Beteiligungs GmbH and others have backed a €2.6m series-B round for German biotech business Transcatheter Technologies, a developer of transcatheter heart valve technology.
The funding round saw existing investors HTGF and Tubaflex joined by new backers, which remain undisclosed.
The business will use the funding to take its flagship product Trinity, a device for transcatheter aortic valve implantation, to clinical trials.
Transcatheter Tech has received two previous funding rounds: a €1.7m series-A round from HTGF in 2011 and a €600,000 seed financing from HTGF and Bayern Kapital in 2009.
Company
Transcatheter Tech was founded in Regensburg in 2009. The biotech firm is in the process of developing a proprietary system for transcatheter aortic valve implantation called Trinity.
People
Rolf Käse of Tubaflex was lead investor in this round. He is also chairman of the company's advisory board.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








